CoChat

A Review of Theranostics: Perspectives on Emerging Approaches and Clinical Advancements

Open access
Burkett, Brian J., Bartlett, David J., McGarrah, Patrick W., Lewis, Akeem R., Johnson, Derek R., Berberoğlu, Kezban, Pandey, Mukesh K., Packard, Annie T., Halfdanarson, Thorvardur R., Hruska, Carrie B., Johnson, Geoffrey B., Kendi, A. Tuba · 2023 · Radiology: Imaging Cancer
Cited by 217

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Theranostics is the combination of two approaches—diagnostics and therapeutics—applied for decades in cancer imaging using radiopharmaceuticals or paired radiopharmaceuticals to image and selectively treat various cancers. The clinical use of theranostics has increased in recent years, with U.S. Food and Drug Administration (FDA) approval of lutetium 177 (177Lu) tetraazacyclododecane tetraacetic acid octreotate (DOTATATE) and 177Lu–prostate-specific membrane antigen vector-based radionuclide therapies. The field of theranostics has imminent potential for emerging clinical applications. This article reviews critical areas of active clinical advancement in theranostics, including forthcoming clinical trials advancing FDA-approved and emerging radiopharmaceuticals, approaches to dosimetry calculations, imaging of different radionuclide therapies, expanded indications for currently used theranostic agents to treat a broader array of cancers, and emerging ideas in the field. Keywords: Molecular Imaging, Molecular Imaging–Cancer, Molecular Imaging–Clinical Translation, Molecular Imaging–Target Development, PET/CT, SPECT/CT, Radionuclide Therapy, Dosimetry, Oncology, Radiobiology © RSNA, 2023

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1148/rycan.220157

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 87

  1. 10.1038/s41598-019-54884-7 · DOI
  2. 10.2214/AJR.19.21123 · DOI
  3. Modoni S, 2021, Q J Nucl Med Mol Imaging, 65, 299
  4. 10.1001/jama.1983.03340150084036 · doi:10.1001/jama.1983.03340150084036
  5. Kassis AI, 2005, J Nucl Med, 46, 4S
  6. 10.1001/jamaoncol.2018.4044 · DOI · Paper page
  7. 10.1186/s13550-014-0038-2 · DOI
  8. 10.3390/cancers13153676 · DOI
  9. 10.1186/s41181-019-0075-2 · DOI · Paper page
  10. 10.1016/S1470-2045(21)00657-4 · DOI
  11. 10.2967/jnumed.108.053173 · DOI · Paper page
  12. 10.1056/NEJM198310203091601 · DOI · Paper page
  13. 10.1089/105072502753522356 · DOI
  14. 10.1097/CCO.0000000000000691 · DOI
  15. 10.1007/s00259-017-3678-4 · DOI · Paper page
  16. 10.2214/AJR.19.22626 · DOI
  17. 10.1159/000337634 · doi:10.1159/000337634
  18. 10.1053/j.semnuclmed.2009.11.004 · doi:10.1053/j.semnuclmed.2009.11.004
  19. 10.1158/1078-0432.CCR-16-2955 · DOI · Paper page
  20. 10.1148/radiol.2020201745 · DOI
  21. 10.1016/S1470-2045(21)00572-6 · DOI · Paper page
  22. Nicolas G, 2015, J Nucl Med, 56, 335
  23. 10.1111/bju.14876 · DOI · Paper page
  24. 10.1002/jmrs.227 · DOI · Paper page
  25. Mullard A, 2022, Nat Rev Drug Discov, 21, 327
  26. 10.2967/jnumed.116.178673 · DOI · Paper page
  27. 10.1038/s41391-021-00349-w · DOI
  28. 10.1016/j.clon.2020.10.020 · DOI
  29. 10.1016/S0140-6736(89)91258-0 · DOI · Paper page
  30. 10.1007/s00259-022-06089-w · DOI · Paper page
  31. 10.2967/jnumed.118.230607 · DOI · Paper page
  32. 10.1016/j.euo.2022.05.003 · DOI
  33. 10.2967/jnumed.122.264860 · DOI
  34. 10.1007/s00259-019-04485-3 · DOI · Paper page
  35. 10.2967/jnumed.122.264398 · DOI
  36. 10.3390/diagnostics12020528 · DOI
  37. 10.1210/jc.2017-00816 · DOI
  38. 10.3390/jcm8070952 · DOI
  39. Forrer F, 2008, Q J Nucl Med Mol Imaging, 52, 334
  40. 10.1007/s12032-016-0737-9 · DOI
  41. 10.1007/s00259-015-3029-2 · doi:10.1007/s00259-015-3029-2
  42. van Essen M, 2006, J Nucl Med, 47, 1599
  43. 10.1055/s-0032-1311637 · doi:10.1055/s-0032-1311637
  44. 10.6004/jnccn.2018.0056 · DOI · Paper page
  45. 10.1007/s00259-016-3527-x · DOI
  46. 10.1158/1078-0432.CCR-20-3703 · DOI
  47. 10.1007/s00259-009-1115-z · DOI
  48. Seystahl K, 2016, Neuro-oncol, 18, 1538
  49. 10.1016/j.mayocpiqo.2020.09.015 · DOI
  50. Van de Wiele C, 2020, Histol Histopathol, 35, 919
  51. 10.1007/s00259-021-05433-w · DOI
  52. 10.1007/s00259-020-04715-z · doi:10.1007/s00259-020-04715-z
  53. 10.1097/RLU.0000000000003142 · doi:10.1097/rlu.0000000000003142
  54. 10.4103/wjnm.WJNM_112_18 · doi:10.4103/wjnm.wjnm_112_18
  55. 10.2967/jnumed.120.257915 · DOI
  56. 10.2967/jnumed.109.068957 · DOI · Paper page
  57. 10.1007/s00259-013-2547-z · DOI
  58. 10.1200/JCO.2022.40.16_suppl.e16212 · doi:10.1200/jco.2022.40.16_suppl.e16212
  59. 10.1155/2021/6615511 · DOI
  60. 10.1016/j.ctrv.2020.102141 · DOI
  61. 10.1056/NEJMoa1209288 · DOI · Paper page
  62. Freudenberg LS, 2007, Nucl Med (Stuttg), 46, 121
  63. 10.2967/jnumed.114.148437 · DOI · Paper page
  64. 10.1007/s00259-017-3688-2 · DOI
  65. 10.2967/jnumed.115.159012 · DOI · Paper page
  66. Macapinlac HA, 1996, J Nucl Med, 37, 25S
  67. 10.1093/annonc/10.suppl_2.S23 · DOI · Paper page
  68. 10.1053/snuc/2002.31025 · DOI · Paper page
  69. Vallis KA, 2014, Am J Nucl Med Mol Imaging, 4, 181
  70. 10.3171/2010.2.JNS091211 · DOI
  71. 10.1016/j.cpet.2021.03.010 · DOI
  72. 10.3390/cancers13225766 · DOI
  73. 10.1007/s00259-019-04504-3 · DOI
  74. 10.2967/jnumed.116.176636 · DOI
  75. 10.2967/jnumed.119.227967 · DOI · Paper page
  76. 10.2967/jnumed.118.210443 · DOI · Paper page
  77. 10.3389/fonc.2021.758958 · DOI
  78. 10.1097/RLU.0000000000003810 · DOI · Paper page
  79. 10.2967/jnumed.120.259192 · DOI · Paper page
  80. Ferdinandus J, 2022, J Nucl Med, 63, 727
  81. 10.2967/jnumed.118.224469 · DOI · Paper page
  82. 10.1007/s00259-020-05023-2 · doi:10.1007/s00259-020-05023-2
  83. Bal C, 2020, J Nucl Med, 61, 416
  84. 10.2967/jnumed.122.264456 · DOI
  85. 10.1159/000434723 · DOI · Paper page
  86. 10.1530/ERC-21-0082 · doi:10.1530/erc-21-0082
  87. 10.1200/JCO.2022.40.16_suppl.4122 · doi:10.1200/jco.2022.40.16_suppl.4122

Cited by

See all 217

Metadata

Authors
Burkett, B. J., Bartlett, D. J., McGarrah, P. W., Lewis, A. R., Johnson, D. R., Berberoğlu, K., Pandey, M. K., Packard, A. T., Halfdanarson, T. R., Hruska, C. B., Johnson, G. B., & Kendi, A. T.
Venue
Radiology: Imaging Cancer
Published
2023-07-01
Volume
5
Issue
4
Pages
e220157-e220157
ISSN
2638-616X (ISSN-L)
OpenAlex
W4384925643
Cited by
217
References
7
FWCI
32.03
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.